Matthew Ros
Directeur/Membre du Conseil chez COGENT BIOSCIENCES, INC.
Fortune : - $ au 31/05/2024
Postes actifs de Matthew Ros
Sociétés | Poste | Début | Fin |
---|---|---|---|
COGENT BIOSCIENCES, INC. | Directeur/Membre du Conseil | 26/07/2019 | - |
Independent Dir/Board Member | 26/07/2019 | - |
Historique de carrière de Matthew Ros
Anciens postes connus de Matthew Ros
Sociétés | Poste | Début | Fin |
---|---|---|---|
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Directeur/Membre du Conseil | 18/04/2022 | 01/08/2023 |
Directeur Général | 18/04/2022 | 01/08/2023 | |
EPIZYME, INC. | Directeur des opérations | 16/05/2016 | 30/09/2018 |
Directeur Financier/CFO | 16/07/2021 | 01/10/2021 | |
Corporate Officer/Principal | 30/09/2018 | 16/07/2021 | |
SANOFI | Directeur des opérations | 01/12/2014 | 01/05/2016 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/09/2012 | 01/12/2014 |
SANOFI | Corporate Officer/Principal | 01/09/2010 | 01/09/2012 |
ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 13/04/2009 | 01/06/2010 |
Sales & Marketing | 01/10/2007 | 13/04/2009 | |
BRISTOL-MYERS SQUIBB COMPANY | Directeur/Membre du Conseil | 01/01/1990 | 01/01/2007 |
Cancer Care, Inc.
Cancer Care, Inc. Hospital/Nursing ManagementHealth Services Cancer Care, Inc. provides cancer treatment services. The firm's services include counseling and support groups, education, financial assistance and practical help. The company was founded in 1944 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - | - |
Formation de Matthew Ros
The State University of New York | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 9 |
France | 2 |
Opérationnelle
Corporate Officer/Principal | 4 |
Director/Board Member | 4 |
Chief Operating Officer | 2 |
Sectorielle
Health Technology | 8 |
Consumer Services | 2 |
Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
COGENT BIOSCIENCES, INC. | Health Technology |
SANOFI | Health Technology |
Entreprise privées | 5 |
---|---|
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Cancer Care, Inc.
Cancer Care, Inc. Hospital/Nursing ManagementHealth Services Cancer Care, Inc. provides cancer treatment services. The firm's services include counseling and support groups, education, financial assistance and practical help. The company was founded in 1944 and is headquartered in New York, NY. | Health Services |
Epizyme, Inc.
Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Health Technology |
- Bourse
- Insiders
- Matthew Ros
- Expérience